Nxera Pharma Posts Revenue Surge Amid Net Loss
Company Announcements

Nxera Pharma Posts Revenue Surge Amid Net Loss

Sosei Group (JP:4565) has released an update.

Nxera Pharma Co., Ltd, formerly known as Sosei Group Corporation, reported a substantial year-on-year revenue increase to 12,720 million yen for the first half of 2024, but also a net loss of 4,703 million yen. The company’s equity has risen to 68,980 million yen, comprising 44.1% of total assets. Due to the difficulty in forecasting, no full-year financial results estimate for 2024 has been provided.

For further insights into JP:4565 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Japan Auto-Generated NewsdeskNxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
TipRanks Auto-Generated NewsdeskNxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
TipRanks Japan Auto-Generated NewsdeskNxera Pharma Reports Increased Revenue but Continues to Face Losses
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App